Malik Fady Ibraham bought CYTK

November 4, 2025 · Form 4 insider transaction

Malik Fady Ibraham bought 2,295 shares of Cytokinetics, Incorporated at $10.60 per share, a transaction worth $24.3K. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 0 days after the transaction.